| |
| |
|
| Insider
Information: |
Mckinney Robert A |
| Relationship: |
Senior VP, CFO |
| City: |
Danbury |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
44,415 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$182,102 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,415 |
|
|
| Total
Value |
$182,102 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Senior VP, CFO |
2011-10-03 |
44,415 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-01-29 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,694 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-02-12 |
4 |
AS |
$29.48 |
$117,908 |
D/D |
(4,000) |
22,694 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-02-12 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,694 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-04-02 |
4 |
OE |
$20.13 |
$9,381 |
D/D |
466 |
23,211 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-04-02 |
4 |
D |
$24.10 |
$10,122 |
D/D |
(420) |
22,791 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-06-20 |
4 |
D |
$22.83 |
$68,490 |
D/D |
(3,000) |
19,791 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,333 |
33,124 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-07-02 |
4/A |
A |
$0.00 |
$0 |
D/D |
13,333 |
33,124 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-07-02 |
4/A |
OE |
$18.71 |
$35,717 |
D/D |
1,909 |
35,084 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-07-02 |
4/A |
D |
$22.01 |
$38,231 |
D/D |
(1,737) |
33,347 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$10,752 |
D/D |
565 |
33,962 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$11,508 |
D/D |
(514) |
33,448 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-01-02 |
4 |
OE |
$15.33 |
$10,608 |
D/D |
692 |
34,201 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$11,359 |
D/D |
(630) |
33,571 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-04-01 |
4 |
OE |
$6.52 |
$12,479 |
D/D |
1,914 |
35,654 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-04-01 |
4 |
D |
$7.67 |
$13,361 |
D/D |
(1,742) |
33,912 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-06-20 |
4 |
D |
$17.15 |
$79,986 |
D/D |
(4,665) |
29,247 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
37,913 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-07-01 |
4 |
D |
$16.05 |
$42,661 |
D/D |
(2,658) |
29,580 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-07-01 |
4 |
OE |
$13.64 |
$39,842 |
D/D |
2,921 |
32,238 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-10-01 |
4 |
OE |
$6.53 |
$11,878 |
D/D |
1,819 |
40,241 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2008-10-01 |
4 |
D |
$13.93 |
$17,259 |
D/D |
(1,239) |
39,002 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-01-02 |
4 |
OE |
$9.13 |
$12,371 |
D/D |
1,355 |
40,464 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-01-02 |
4 |
D |
$10.74 |
$13,242 |
D/D |
(1,233) |
39,231 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2009-04-01 |
4 |
OE |
$5.65 |
$11,978 |
D/D |
2,120 |
39,590 |
0 |
- |
|
96 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
